Articles

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Medical University of Vienna, Dept. of Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Vienna, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Institute of Hematology and Blood Transfusion, 1st Dept. of Medicine, 1st Faculty of Medicine, Charles University, General Hospital, Czech Lymphoma Study Group, Praha, Czech Republic
Medical University of Vienna, Dept. of Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Vienna, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Assign Data Management and Biostatistics GmbH Assign Group, Innsbruck, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Dept. of Internal Medicine, Faculty of Medicine, Chiang Mai University, Thailand
Dept. of Hematology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
Australasian Leukaemia & Lymphoma Group, East Melbourne, Australia
Clinic for Hematology, Clinical Center Serbia, Belgrade, Serbia
Ankara University School of Medicine, Dept. of Hematology, Ankara, Turkey
NOU, Klenova Bratislava, Slovakia
Dept. of Internal Medicine, Sundsvall Hospital, Sweden
Division of Hematology and Oncology, Dept. of Medicine, Taipei Veterans General Hospital, and National Yang-Ming University, Taipei, Taiwan
University Medical Unit, Queen Mary Hospital, Hong Kong, China
Dept. of Internal Medicine IV, Wels-Grieskirchen Hospital, Wels, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
1st Medical Dept., Landesklinikum Wiener Neustadt, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
3rd Medical Dept., Hanusch Hospital, Vienna, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
LBI-ACR & ACR-ITR Vienna, Kaiser Franz Josef-Spital, Vienna, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Medical University of Vienna, Dept. of Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Vienna, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Assign Data Management and Biostatistics GmbH Assign Group, Innsbruck, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Institute of Pathology and Microbiology, Wilhelminenspital, Vienna, Austria
3rd Dept. of Medicine, AKH-Linz, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Dept. of Internal Medicine III, Private Medical University of Salzburg, Austria;Arbeitsgemeinschaft Medikamentöse Tumortherapie, AGMT, Salzburg, Austria
Vol. 100 No. 7 (2015): July, 2015 https://doi.org/10.3324/haematol.2015.125344